A new study by Dana-Farber Cancer Institute investigators demonstrates that vitamin D can protect some people with colorectal cancer by perking up the immune system's vigilance against tumor cells.
Jan 15, 2015
0
128
Already known to cut proteins, the enzyme SPPL3 turns out to have additional talents, according to a new study from Johns Hopkins. In its newly discovered role, SPPL3 works without cutting proteins to activate T cells, the ...
Dec 29, 2014
1
0
Researchers at Yale and Boston University and their Russian collaborators have found that occasional heroin use by HIV-positive patients may be particularly harmful to the immune system and worsens HIV disease, compared to ...
Dec 15, 2014
0
0
Scientists at the University of Southampton have discovered variations in an enzyme belonging to the immune system that leaves individuals susceptible to Ankylosing Spondylitis.
Dec 9, 2014
0
1
Almost everyone knows that improving your eating habits will most likely improve your health. What most people may not know, however, is that the effects of poor eating habits persist long after dietary habits are improved. ...
Nov 3, 2014
0
1
Research by UC Irvine immunologists reveals new information about how our immune system functions, shedding light on a vital process that determines how the body's ability to fight infection develops.
Sep 30, 2014
0
0
Researchers working on the European BLUEPRINT initiative (EBI) have published three papers in the journal Science, each outlining their part of the overall mission and explaining what they have found thus far. The initiative ...
Young people have a more robust immune response to the loss of a loved one, according to new research from the University of Birmingham, providing insight into how different generations cope with loss.
Sep 9, 2014
0
0
Glass crystals with thread-like filaments floating inside sit in the offices of two prominent immunologists. The clear blocks encase models of the structure of PD-1/PD-L1, a receptor-ligand pair that rides on the surface ...
Sep 8, 2014
0
0
Six or so years ago, Frank Longo, MD, PhD, Stanford's chair of neurology and neurological sciences, was optimistic that a treatment for Alzheimer's disease was on its way. More than a decade earlier, pharmaceutical companies ...
Aug 19, 2014
0
0
